Discover 1,609 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,609
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
for
Sjögren's Syndrome
Location: Durham NC, Charlotte NC, Salisbury NC, Beckley WV,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06747949
Phase3, Recruiting
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
for
Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors,
Location: Durham NC, Washington D.C. DC, Cincinnati OH,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 1 - 70+
Code: NCT05868629
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Location: Durham NC, Fairfax VA, Cleveland OH, New York NY,
Sponsor: Plexium, Inc.
Sex: All
Age: 18+
Code: NCT07284186
Phase1, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Durham NC, Chapel Hill NC, Charlottesville VA,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase3, Recruiting
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
for
Cardiovascular, Metabolic Disease, Dyslipidemias,
Location: Durham NC, High Point NC, Jacksonville FL,
Sponsor: CRISPR Therapeutics AG
Sex: All
Age: 18 - 70+
Code: NCT07491172
Phase1, Recruiting
COA-APTIC Cognitive Interview Study of Caregiver and Clinician Assessment of Acute Pain in Infants and Young Children
for
Acute Pain
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06164028
Recruiting
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
for
Systemic Lupus Erythematosus
Location: Durham NC, Washington D.C. DC, Philadelphia PA,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 17
Code: NCT05835310
Phase3, Recruiting
A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
for
Glycogen Storage Disease Type II Infantile Onset
Location: Durham NC, Pittsburgh PA, Atlanta GA, Cincinnati OH,
Sponsor: Amicus Therapeutics
Sex: All
Age: 0 - 17
Code: NCT04808505
Phase3, Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
for
Heart Failure and Impaired Kidney Function
Location: Durham NC, Chapel Hill NC, Pinehurst NC, Wilmington NC,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06307652
Phase3, Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: Durham NC, Charlotte NC, Summerville SC, Charleston SC,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase3, Recruiting
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
for
Cutaneous Sarcoidosis
Location: Durham NC, Philadelphia PA, Madison WI,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06978725
Phase2, Phase3, Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
for
Type 1 Diabetes
Location: Chapel Hill NC, Charlottesville VA, Asheville NC,
Sponsor: SAb Biotherapeutics, Inc.
Sex: All
Age: 5 - 40
Code: NCT07187531
Phase2, Recruiting
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases